| Literature DB >> 19786134 |
Ron P Schuring1, Jan Hendrik Richardus, David Pahan, Linda Oskam.
Abstract
BCG vaccination and rifampicin chemoprophylaxis are both strategies for leprosy prevention. While the combined effect is unknown, the combination may give the desired push to halt leprosy transmission. Secondary analysis was done on results from a single centre, double blind, cluster randomized, and placebo-controlled trial. Individually, BCG (given at infancy) and rifampicin showed to protect against leprosy (57% [95% CI: 24-75%] and 58% [95% CI: 30-74%], respectively). The combined strategies showed a protective effect of 80% (95% CI: 50-92%). This is the first time that the additive effect of BCG and rifampicin are shown; the combined strategies can possibly lower leprosy incidence.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19786134 DOI： 10.1016/j.vaccine.2009.09.054
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641